OBJECTIVE: Endoscopic thoracic sympathectomy or sympathicotomy, for the treatment of palmar, axillary, and plantar @entity1119 , is generally performed at one or two levels, between T2 and T5. @entity3190 ( @entity3190 ) is a severe and undesirable side effect of this procedure. Here, we describe the success of treatment and degree of postoperative @entity3190 in sympathicotomy @entity1 . SUBJECTS AND METHODS: This study included 80 @entity1 treated by uniportal (5-mm) thoracoscopic sympathicotomy (electrocautery) for primary @entity1119 over a 6-year period (2007-2013). Sympathicotomy was performed bilaterally at T2 for blushing (n=2), T2-T3 for palmar-only @entity1119 (n=34), T2-T4 for palmar and axillary @entity1119 (n=39), and T3-T4 for axillary-only @entity1119 (n=5). Outcome was assessed 2 weeks postsurgery at the clinic and annually thereafter by telephone questionnaire. Mean follow-up time was 35.2  23.3 months. Questionnaires assessed @entity1 ' degree of sweating, postoperative @entity3190 , overall satisfaction, and complications. RESULTS: Seventy-one @entity1 (88.7%) were very satisfied, whereas only 9 (11.3%) were dissatisfied with the procedure. Complication incidence was 7.5%, and @entity3190 occurred in 77.5% of @entity1 . Therapeutic success rate was 97.5%; complete relief of @entity1119 was achieved in 72 (90%) @entity1 , whereas 8 (10%) experienced recurrence. CONCLUSIONS: @entity3190 is a frequent side effect of thoracoscopic sympathicotomy. We recommend all @entity1 undergoing this procedure should be warned of the potential risk of developing severe @entity3190 .

3-year follow-up after uniportal thoracoscopic sympathicotomy for XXXX : undesirable side effects.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1119 :: ('MESH:D006945', 'Disease') :: ['hyperhidrosis'] @entity3190 :: ('MESH:D006946', 'Disease') :: ['Compensatory sweating', 'CS']
@entity1119 :: (MESH:D006945,Disease) :: ['hyperhidrosis']
